Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 856793, 10 pages
http://dx.doi.org/10.1155/2013/856793
Review Article

Challenges in the Management of Type 2 Diabetes Mellitus and Cardiovascular Risk Factors in Obese Subjects: What Is the Evidence and What Are the Myths?

1Department of Internal Medicine, Saint Vincent Hospital, University of Massachusetts Medical School, Worcester, MA 01608, USA
2Department of Endocrinology, Saint Vincent Hospital, University of Massachusetts Medical School, Worcester, MA 01608, USA

Received 25 April 2013; Accepted 19 May 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 Lovely Chhabra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. N. Chan, V. Malik, W. Jia et al., “Diabetes in Asia: epidemiology, risk factors, and pathophysiology,” The Journal of the American Medical Association, vol. 301, no. 20, pp. 2129–2140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Ogden and M. D. Carroll, Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2007-2008, National Center for Health Statistics, 2010.
  3. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2011.
  4. J. P. Boyle, T. J. Thompson, E. W. Gregg, L. E. Barker, and D. F. Williamson, “Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence,” Population Health Metrics, vol. 8, article 29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Sherwin and A. M. Jastreboff, “Year in diabetes 2012: the diabetes tsunami,” Journal of Clinical Endocrinology & Metabolism, vol. 12, pp. 4293–4301, 2012. View at Google Scholar
  6. P. Zimmet, K. G. M. M. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. Buse, S. Caprio, W. T. Cefalu et al., “How do we define cure of diabetes?” Diabetes Care, vol. 32, no. 11, pp. 2133–2135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Nathan, J. B. Buse, M. B. Davidson et al., “Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetes Care, vol. 32, pp. 193–203, 2009. View at Google Scholar
  9. E. W. Gregg, H. Chen, L. E. Wagenknecht et al., “Association of an intensive lifestyle intervention with remission of type 2 diabetes,” The Journal of the American Medical Association, vol. 308, pp. 2489–2496, 2012. View at Google Scholar
  10. D. E. Arterburn and P. J. O'Connor, “A look ahead at the future of diabetes prevention and treatment,” The Journal of the American Medical Association, vol. 308, pp. 2517–2518, 2012. View at Google Scholar
  11. H. C. Gerstein, M. E. Miller, S. Genuth et al., “Long-term effects of intensive glucose lowering on cardiovascular outcomes,” The New England Journal of Medicine, vol. 364, no. 9, pp. 818–828, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Patel, S. MacMahon, J. Chalmers et al., “Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2560–2572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Duckworth, C. Abraira, T. Moritz et al., “Glucose control and vascular complications in veterans with type 2 diabetes,” The New England Journal of Medicine, vol. 360, no. 2, pp. 129–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. P. T. James, I. D. Caterson, W. Coutinho et al., “Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects,” The New England Journal of Medicine, vol. 363, no. 10, pp. 905–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Rucker, R. Padwal, S. K. Li, C. Curioni, and D. C. W. Lau, “Long term pharmacotherapy for obesity and overweight: updated meta-analysis,” British Medical Journal, vol. 335, no. 7631, pp. 1194–1199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Gæde, P. Vedel, N. Larsen, G. V. H. Jensen, H. H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 348, no. 5, pp. 383–393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Gæde, H. Lund-Andersen, H. H. Parving, and O. Pedersen, “Effect of a multifactorial intervention on mortality in type 2 diabetes,” The New England Journal of Medicine, vol. 358, no. 6, pp. 580–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, “10-Year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, no. 15, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. N. V. Christou, J. S. Sampalis, M. Liberman et al., “Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients,” Annals of Surgery, vol. 240, no. 3, pp. 416–424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Sjöström, K. Narbro, C. D. Sjöström et al., “Effects of bariatric surgery on mortality in Swedish obese subjects,” The New England Journal of Medicine, vol. 357, pp. 741–752, 2007. View at Google Scholar
  21. T. D. Adams, R. E. Gress, S. C. Smith et al., “Long-term mortality after gastric bypass surgery,” The New England Journal of Medicine, vol. 357, no. 8, pp. 753–761, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Buchwald, R. Estok, K. Fahrbach et al., “Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis,” American Journal of Medicine, vol. 122, no. 3, pp. 248.e5–256.e5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Arterburn, A. Bogart, K. J. Coleman et al., “Comparative effectiveness of bariatric surgery vs nonsurgical treatment of type 2 diabetes among severely obese adults,” Obesity Research & Clinical Practice, 2012. View at Publisher · View at Google Scholar
  24. D. E. Arterburn, A. Bogart, N. E. Sherwood et al., “A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass,” Obesity Surgery, vol. 23, pp. 93–102, 2013. View at Google Scholar
  25. T. D. Adams, L. E. Davidson, S. E. Litwin et al., “Health benefits of gastric bypass surgery after 6 years,” The Journal of the American Medical Association, vol. 308, pp. 1122–1131, 2012. View at Google Scholar
  26. L. Sjöström, A. K. Lindroos, M. Peltonen et al., “Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery,” The New England Journal of Medicine, vol. 351, pp. 2683–2693, 2004. View at Google Scholar
  27. L. Sjöström, M. Peltonen, P. Jacobson et al., “Bariatric surgery and long-term cardiovascular events,” The Journal of the American Medical Association, vol. 307, pp. 56–65, 2012. View at Google Scholar
  28. D. Hofsø, N. Nordstrand, L. K. Johnson et al., “Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention,” European Journal of Endocrinology, vol. 163, no. 5, pp. 735–745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. R. Schauer, S. R. Kashyap, K. Wolski et al., “Bariatric surgery versus intensive medical therapy in obese patients with diabetes,” The New England Journal of Medicine, vol. 366, no. 17, pp. 1567–1576, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Mingrone, S. Panunzi, A. De Gaetano et al., “Bariatric surgery versus conventional medical therapy for type 2 diabetes,” The New England Journal of Medicine, vol. 366, no. 17, pp. 1577–1585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Maggard, L. R. Shugarman, M. Suttorp et al., “Meta-analysis: surgical treatment of obesity,” Annals of Internal Medicine, vol. 142, no. 7, pp. 547–559, 2005. View at Google Scholar
  32. “NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel,” Annals of Internal Medicine, vol. 115, no. 12, pp. 956–961, 1991.
  33. F. Abbatini, D. Capoccia, G. Casella, F. Coccia, F. Leonetti, and N. Basso, “Type 2 diabetes in obese patients with body mass index of 3035 kg/m2: sleeve gastrectomy versus medical treatment,” Surgery for Obesity and Related Diseases, vol. 8, no. 1, pp. 20–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. T. P. Kakoulidis, Å. Karringer, T. Gloaguen, and D. Arvidsson, “Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30–35 kg/m2),” Surgery for Obesity and Related Diseases, vol. 5, no. 4, pp. 425–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. V. Cohen, J. C. Pinheiro, C. A. Schiavon, J. E. Salles, B. L. Wajchenberg, and D. E. Cummings, “Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity,” Diabetes Care, vol. 35, pp. 1420–1428, 2012. View at Google Scholar
  36. S. G. Mattar, L. M. Velcu, M. Rabinovitz et al., “Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome,” Annals of Surgery, vol. 242, no. 4, pp. 610–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Reed, W. J. Pories, W. Chapman et al., “Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 8, pp. 2525–2531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Sell, A. Divoux, C. Poitou et al., “Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2892–2896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Estruch, E. Ros, J. Salas-Salvadó et al., “Primary prevention of cardiovascular disease with a Mediterranean diet,” The New England Journal of Medicine, vol. 368, no. 14, pp. 1279–1290, 2013. View at Google Scholar
  40. “Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial,” American Journal of Cardiology, vol. 75, pp. 894–903, 1995.
  41. UK Prospective Diabetes Study Group, “Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38,” British Medical Journal, vol. 317, no. 7160, pp. 703–713, 1998. View at Google Scholar · View at Scopus
  42. W. J. Pories, M. S. Swanson, K. G. MacDonald et al., “Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus,” Annals of Surgery, vol. 222, no. 3, pp. 339–352, 1995. View at Google Scholar · View at Scopus
  43. W. J. Pories and R. J. Albrecht, “Etiology of type II diabetes mellitus: role of the foregut,” World Journal of Surgery, vol. 25, no. 4, pp. 527–531, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Hickey, W. J. Pories, K. G. MacDonald Jr. et al., “A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?” Annals of Surgery, vol. 227, no. 5, pp. 637–644, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Rubino, A. Forgione, D. E. Cummings et al., “The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes,” Annals of Surgery, vol. 244, no. 5, pp. 741–749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Mingrone, F. L. Henriksen, A. V. Greco et al., “Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency,” Diabetes, vol. 48, no. 6, pp. 1258–1263, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Linde, R. W. Jeffery, R. L. Levy, N. P. Pronk, and R. G. Boyle, “Weight loss goals and treatment outcomes among overweight men and women enrolled in a weight loss trial,” International Journal of Obesity, vol. 29, no. 8, pp. 1002–1005, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Casazza, K. R. Fontaine, A. Astrup et al., “Myths, presumptions, and facts about obesity,” The New England Journal of Medicine, vol. 368, no. 5, pp. 446–454, 2013. View at Google Scholar
  49. A. Astrup and S. Rössner, “Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance,” Obesity Reviews, vol. 1, no. 1, pp. 17–19, 2000. View at Google Scholar · View at Scopus
  50. J. G. Bohlen, J. P. Held, M. O. Sanderson, and R. P. Patterson, “Heart rate, rate-pressure product, and oxygen uptake during four sexual activities,” Archives of Internal Medicine, vol. 144, no. 9, pp. 1745–1748, 1984. View at Publisher · View at Google Scholar · View at Scopus
  51. B. L. Horta, R. Bahl, J. C. Martinés, and C. G. Victora, Evidence of the Long-Term Effects of Breastfeeding: Systematic Reviews and Meta-Analyses, World Health Organization, Geneva, Switzerland, 2007.
  52. A. I. Eidelman and R. J. Schanler, “Breastfeeding and the use of human milk,” Pediatrics, vol. 129, no. 3, pp. e827–e841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Casazza, J. R. Fernandez, and D. B. Allison, “Modest protective effects of breast-feeding on obesity: is the evidence truly supportive?” Nutrition Today, vol. 47, no. 1, pp. 33–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. W. Gillman, “Commentary: breastfeeding and obesity—the 2011 scorecard,” International Journal of Epidemiology, vol. 40, no. 3, pp. 681–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Kramer, E. Fombonne, S. Igumnov et al., “Effects of prolonged and exclusive breastfeeding on child behavior and maternal adjustment: evidence from a large, randomized trial,” Pediatrics, vol. 121, no. 3, pp. e435–e440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. K. Hewitt, “The genetics of obesity: what have genetic studies told us about the environment,” Behavior Genetics, vol. 27, no. 4, pp. 353–358, 1997. View at Publisher · View at Google Scholar · View at Scopus